WebApr 6, 2024 · Day Low 1.42. Prev Close 1.46. 52 Week High 4.16. 52 Week High Date 02/14/23. 52 Week Low 0.51. 52 Week Low Date 06/16/22. Market Cap 75.228M. … WebApr 6, 2024 · According to 9 analysts, the average rating for GLYC stock is "Buy." The 12-month stock price forecast is $5.61, which is an increase of 341.73% from the latest price.
GlycoMimetics, Inc. (GLYC) Stock Price, News, Quote & History
WebApr 6, 2024 · Compare with up to 5 Stocks. On Thursday morning 03/30/2024 the GlycoMimetics Inc share started trading at the price of $1.25. Compared to the closing price on Wednesday 03/29/2024 on NAS of $1.27 ... WebThe average Glycomimetics stock price prediction forecasts a potential upside of 501.5% from the current GLYC share price of $1.33. What is GLYC's forecast return on assets (ROA) for 2024-2026? (NASDAQ: GLYC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.13%. second level eligibility csc
GLYC GlycoMimetics Inc. Stock Price & News - WSJ
WebFeb 15, 2024 · In a report released on February 10, Jefferies also maintained a Buy rating on the stock with a $5.00 price target. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4. ... WebJune 13 2016 - 09:00AM. Business Wire. GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its novel E-selectin antagonist GMI-1271 for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) and elderly patients … WebView the latest GlycoMimetics Inc. (GLYC) stock price, news, historical charts, analyst ratings and financial information from WSJ. punta allen fly fishing lodges